Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation | British Journal of Cancer
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
Cancer Clinical Trial Interpretation Videos - YouTube
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
PDF) Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis | NEJM
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | NEJM
NEJM on X: "The POLO trial evaluated the efficacy of maintenance therapy with olaparib in patients with a germline BRCA mutation and metastatic pancreatic adenocarcinoma that had not progressed during first-line platinum-based
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Diapositiva 1
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 11 (2020)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Monumen-TAL - I dismantle the ASH/ NEJM Talquetamab study | First of the ASH 2022 video series - YouTube
Current Oncology | Free Full-Text | Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial | NEJM
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease | NEJM
